Clinical Trials Directory

Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission

Evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation for AML.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • procedure : high dose chemotherapy then autologous hematopoietic cell transplant

Phase: Phase 2


Ages Eligible For Study:

16 Years - 69 Years

Inclusion Criteria

- must be in remission - adequate organ function

External Links

Explore related trials

Contact information

Primary Contact:

BMT Referrals 6507230822

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: